ZA201307677B - Anti-angiogenesis therapy for the treatment of ovarian cancer - Google Patents

Anti-angiogenesis therapy for the treatment of ovarian cancer

Info

Publication number
ZA201307677B
ZA201307677B ZA2013/07677A ZA201307677A ZA201307677B ZA 201307677 B ZA201307677 B ZA 201307677B ZA 2013/07677 A ZA2013/07677 A ZA 2013/07677A ZA 201307677 A ZA201307677 A ZA 201307677A ZA 201307677 B ZA201307677 B ZA 201307677B
Authority
ZA
South Africa
Prior art keywords
treatment
ovarian cancer
angiogenesis therapy
angiogenesis
therapy
Prior art date
Application number
ZA2013/07677A
Inventor
Cornelia Irl
Jakob Dupont
Original Assignee
Genentech Inc
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Hoffmann La Roche filed Critical Genentech Inc
Publication of ZA201307677B publication Critical patent/ZA201307677B/en

Links

ZA2013/07677A 2010-02-23 2013-10-15 Anti-angiogenesis therapy for the treatment of ovarian cancer ZA201307677B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30709510P 2010-02-23 2010-02-23
US35123110P 2010-06-03 2010-06-03
US36005910P 2010-06-30 2010-06-30

Publications (1)

Publication Number Publication Date
ZA201307677B true ZA201307677B (en) 2017-09-27

Family

ID=47290217

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2013/07677A ZA201307677B (en) 2010-02-23 2013-10-15 Anti-angiogenesis therapy for the treatment of ovarian cancer

Country Status (2)

Country Link
CR (1) CR20120436A (en)
ZA (1) ZA201307677B (en)

Also Published As

Publication number Publication date
CR20120436A (en) 2012-11-26

Similar Documents

Publication Publication Date Title
IL258612B (en) Anti-angiogenesis therapy for the treatment of ovarian cancer
HRP20190046T1 (en) Combination therapy for the treatment of cancer
SG10201508495VA (en) Combination treatment of cancer
IL263781A (en) Combination therapy for the treatment of ovarian cancer
EP2830633A4 (en) Combination therapy for the treatment of cancer
HK1214128A1 (en) Treatment of cancer
EP2807111A4 (en) Multifunctional nanomaterials for the treatment of cancer
ZA201300762B (en) Novel combination therapy for the treatment of cancer
HK1185874A1 (en) Novel 4-amino-n-hydroxy-benzamides for the treatment of cancer 4--n--
GB201217892D0 (en) Treatment of cancer
IL275636A (en) Therapeutic combination for the treatment of cancer
HK1204956A1 (en) Treatment of cancer
SI2892925T1 (en) Combination treatment of cancer
PL2855475T3 (en) Alpha-carbolines for the treatment of cancer
EP2849786A4 (en) Methods for treatment of gastric cancer
GB201217890D0 (en) Treatment of cancer
ZA201307677B (en) Anti-angiogenesis therapy for the treatment of ovarian cancer
IL233495A0 (en) Combination therapy for the treatment of cancer
GB201208296D0 (en) Treatment of cancer
GB201017354D0 (en) Treatment of cancer
GB201222950D0 (en) Combination treatment of cancer
GB201222949D0 (en) Combination Treatment of Cancer
GB201017356D0 (en) Combination treatment of cancer
GB201121791D0 (en) Combination treatment of cancer